[Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk].

Abstract

We report the results of the vaccinations against hepatitis B carried out with vaccine H-B-VAX of the commercial firm (Merck Sharp and Dohme), on 102 U.S.L. 32 hospital workers in Portomaggiore (Ferrara, Italy). The vaccine rendered 92% of the subjects inoculated immune and the incidence of secondary effects was low.

• Authors: M Lavezzi, A Donati, D Davi, M C Carpanelli, S Farinelli, E Soracco
• Journal: Quaderni Sclavo di diagnostica clinica e di laboratorio (Quad Sclavo Diagn) Vol. 23 Issue 2 Pg. 164-8 (Jun 1987) ISSN: 0033-4979 [Print] Italy
• Vernacular Title: Risposta alla vaccinazione contro l'agente eziologico dell'epatite virale B (HBV) in una popolazione a rischio.
• PMID: 2967519 (Publication Type: English Abstract, Journal Article)

Chemical References

• Hepatitis B Antibodies
• Hepatitis B Vaccines
• Viral Hepatitis Vaccines

Topics

• Hepatitis B (prevention & control)
• Hepatitis B Antibodies (immunology)
• Hepatitis B Vaccines
• Hepatitis B virus (immunology)
• Humans
• Risk Factors
• Viral Hepatitis Vaccines (therapeutic use)